Eczema drug shows promise in repairing Kids' skin barrier
NCT ID NCT04718870
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tested the drug dupilumab in 41 children aged 6 to 12 with moderate to severe eczema (atopic dermatitis). The goal was to see if the drug improves the skin's barrier function by measuring how much water escapes through the skin. Researchers compared the children's skin to healthy volunteers to track changes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :8260001
Sheffield, S10 2TH, United Kingdom
-
Investigational Site Number :8400001
Denver, Colorado, 80206, United States
-
Investigational Site Number :8400002
Los Angeles, California, 90027, United States
Conditions
Explore the condition pages connected to this study.